Stock listing
Stockholm:ATORX Alligator Bioscience AB Aktie
Home listing (Stockholm) of Alligator Bioscience AB
Follow Alligator Bioscience AB into a list and get an email when it puts out news.
Share price · OMXSTO:ATORX
0.01 SEK -0.00 (-4.7%)
Close on Oct 23, 2026
- Day range
- 0.0096 – 0.011 SEKOct 23, 2026
- Volume
- 123.0M sharesOct 23, 2026
- Market cap
- 36.04M SEKAt the close on Oct 23, 2026 · price × 3.57B shares outstanding
- 52-week range
- 0.0096 – 0.573 SEKLowest and highest trades, Oct 24, 2025 – Oct 23, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:ATORX · Home | 0.01 SEK | -0.001 (-4.7%) | 122,973,635 | 0.011 | 0.011 | 0.0096 | 0.011 | Close on Oct 23, 2026 |
| Frankfurt:7AL0 | €0.0001 EUR | 0.0000 (0.0%) | — | €0.0001 | €0.0001 | €0.0001 | €0.0001 | Close on Oct 23, 2026 |
Daily closes
Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OMXSTO:ATORX · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.01 | -0.001 | -4.7% | 0.011 | 0.011 | 0.0096 | 122,973,635 | |
| 0.011 | 0.00 | -1.9% | 0.011 | 0.011 | 0.0099 | 63,474,371 | |
| 0.011 | -0.001 | -6.9% | 0.012 | 0.013 | 0.011 | 32,693,949 | |
| 0.012 | -0.001 | -7.9% | 0.013 | 0.013 | 0.011 | 44,026,390 | |
| 0.013 | -0.001 | -4.5% | 0.013 | 0.013 | 0.013 | 6,815,229 | |
| 0.013 | +0.00 | +1.5% | 0.013 | 0.013 | 0.013 | 22,150,075 | |
| 0.013 | 0.00 | -3.0% | 0.014 | 0.014 | 0.013 | 12,509,086 | |
| 0.013 | -0.001 | -8.8% | 0.015 | 0.015 | 0.013 | 75,997,507 | |
| 0.015 | +0.00 | +1.4% | 0.015 | 0.022 | 0.015 | 92,561,964 | |
| 0.015 | -0.001 | -5.2% | 0.016 | 0.016 | 0.015 | 11,712,187 | |
| 0.015 | -0.001 | -5.0% | 0.016 | 0.016 | 0.015 | 10,382,603 | |
| 0.016 | -0.001 | -6.9% | 0.017 | 0.017 | 0.015 | 29,633,664 | |
| 0.017 | +0.00 | +0.6% | 0.018 | 0.018 | 0.016 | 10,196,727 | |
| 0.017 | -0.001 | -4.4% | 0.019 | 0.019 | 0.017 | 5,124,857 | |
| 0.018 | -0.001 | -6.7% | 0.02 | 0.021 | 0.018 | 15,525,797 | |
| 0.019 | 0.00 | -2.0% | 0.021 | 0.021 | 0.019 | 1,612,698 | |
| 0.02 | 0.00 | -1.5% | 0.02 | 0.02 | 0.019 | 3,543,122 | |
| 0.02 | -0.001 | -4.3% | 0.021 | 0.022 | 0.019 | 16,005,292 | |
| 0.021 | -0.001 | -5.4% | 0.023 | 0.023 | 0.02 | 4,916,576 | |
| 0.022 | -0.001 | -3.9% | 0.023 | 0.025 | 0.022 | 15,111,387 | |
| 0.023 | +0.003 | +16.2% | 0.02 | 0.025 | 0.02 | 35,046,932 | |
| 0.02 | 0.00 | -2.0% | 0.021 | 0.021 | 0.02 | 2,657,451 | |
| 0.02 | -0.001 | -4.7% | 0.021 | 0.021 | 0.02 | 7,350,637 | |
| 0.021 | +0.00 | +1.0% | 0.021 | 0.022 | 0.02 | 4,516,403 | |
| 0.021 | -0.002 | -8.7% | 0.023 | 0.023 | 0.02 | 18,977,716 | |
| 0.023 | -0.001 | -2.5% | 0.024 | 0.024 | 0.021 | 8,263,185 | |
| 0.024 | +0.00 | +1.3% | 0.024 | 0.025 | 0.023 | 3,163,888 | |
| 0.023 | +0.001 | +4.0% | 0.022 | 0.024 | 0.021 | 10,361,355 | |
| 0.022 | +0.001 | +4.2% | 0.022 | 0.023 | 0.021 | 10,024,366 | |
| 0.022 | -0.001 | -5.7% | 0.023 | 0.024 | 0.021 | 4,188,776 | |
| 0.023 | 0.00 | -0.9% | 0.023 | 0.024 | 0.022 | 5,365,387 | |
| 0.023 | -0.001 | -4.2% | 0.024 | 0.025 | 0.023 | 4,060,089 | |
| 0.024 | 0.00 | 0.0% | 0.025 | 0.025 | 0.022 | 16,793,301 | |
| 0.024 | -0.002 | -7.7% | 0.027 | 0.027 | 0.024 | 12,644,828 | |
| 0.026 | +0.001 | +4.0% | 0.026 | 0.027 | 0.025 | 22,424,924 | |
| 0.025 | -0.001 | -2.7% | 0.026 | 0.027 | 0.025 | 24,731,673 | |
| 0.026 | -0.001 | -2.7% | 0.026 | 0.028 | 0.025 | 17,206,620 | |
| 0.026 | -0.001 | -3.3% | 0.028 | 0.031 | 0.025 | 36,082,633 | |
| 0.027 | +0.006 | +30.1% | 0.031 | 0.039 | 0.025 | 119,458,977 | |
| 0.021 | +0.001 | +3.0% | 0.022 | 0.022 | 0.02 | 19,663,163 | |
| 0.02 | -0.001 | -6.3% | 0.021 | 0.022 | 0.02 | 24,791,624 | |
| 0.022 | -0.002 | -7.5% | 0.023 | 0.024 | 0.02 | 30,385,982 | |
| 0.024 | +0.004 | +22.3% | 0.02 | 0.024 | 0.02 | 86,470,796 | |
| 0.019 | -0.001 | -6.9% | 0.021 | 0.021 | 0.019 | 19,413,458 | |
| 0.021 | 0.00 | -2.3% | 0.021 | 0.021 | 0.02 | 5,568,657 | |
| 0.021 | +0.001 | +2.6% | 0.022 | 0.022 | 0.02 | 18,343,929 | |
| 0.021 | -0.001 | -4.4% | 0.022 | 0.023 | 0.02 | 27,510,582 | |
| 0.022 | +0.001 | +5.7% | 0.021 | 0.025 | 0.02 | 55,372,990 | |
| 0.02 | -0.002 | -9.4% | 0.022 | 0.023 | 0.02 | 41,773,587 | |
| 0.022 | -0.002 | -8.8% | 0.025 | 0.025 | 0.022 | 39,690,895 | |
| 0.025 | 0.00 | -0.8% | 0.025 | 0.026 | 0.024 | 15,055,807 | |
| 0.025 | 0.00 | -0.5% | 0.025 | 0.026 | 0.025 | 14,539,983 | |
| 0.025 | -0.001 | -2.1% | 0.026 | 0.026 | 0.025 | 11,181,209 | |
| 0.026 | 0.00 | -1.1% | 0.026 | 0.026 | 0.025 | 3,407,003 | |
| 0.026 | 0.00 | -1.0% | 0.026 | 0.026 | 0.025 | 19,448,449 | |
| 0.026 | -0.001 | -5.0% | 0.027 | 0.027 | 0.025 | 26,018,763 | |
| 0.027 | -0.001 | -4.3% | 0.029 | 0.029 | 0.027 | 20,422,123 | |
| 0.029 | 0.00 | -0.5% | 0.029 | 0.029 | 0.028 | 9,529,254 | |
| 0.029 | 0.00 | -0.9% | 0.029 | 0.03 | 0.028 | 17,536,102 | |
| 0.029 | 0.00 | 0.0% | 0.029 | 0.03 | 0.027 | 10,506,768 | |
| 0.029 | +0.001 | +4.1% | 0.028 | 0.033 | 0.028 | 39,894,590 | |
| 0.028 | -0.001 | -1.9% | 0.028 | 0.029 | 0.027 | 15,323,878 | |
| 0.028 | 0.00 | -0.9% | 0.029 | 0.03 | 0.028 | 17,704,753 | |
| 0.029 | -0.001 | -3.2% | 0.03 | 0.03 | 0.028 | 27,750,026 | |
| 0.03 | -0.003 | -8.2% | 0.033 | 0.033 | 0.029 | 54,260,618 | |
| 0.032 | -0.002 | -5.6% | 0.034 | 0.035 | 0.031 | 72,762,956 | |
| 0.034 | -0.098 | -74.0% | 0.03 | 0.048 | 0.022 | 337,482,440 |
- Ticker
- Stockholm:ATORX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stockholm
- Currency
- SEK
What changed lately
Latest news release · Oct 4, 2026
Alligator Bioscience appoints Johan Giléus as CEO – Søren Bregenholt to step down at year-end
Latest earnings call · Aug 26, 2026
Alligator Bioscience (Stockholm:ATORX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 15 slides
Calls
Replays
Alligator Bioscience (Stockholm:ATORX) Q2 2026 Earnings Call
Wed, Aug 26, 2026 · 9:00 AM ET
Watch TranscriptAlligator Bioscience (Stockholm:ATORX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 7:00 AM ET
Watch TranscriptAlligator Bioscience (Stockholm:ATORX) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 9:00 AM ET
Watch Transcript
Latest news
Alligator Bioscience appoints Johan Giléus as CEO – Søren Bregenholt to step down at year-end
Oct 4, 2026
Closed 0.018 (-6.7%) on Oct 5, 2026
Alligator Bioscience carries out a directed issue of warrants to Fenja Capital in connection with the completed rights issue
Sep 29, 2026
Closed 0.021 (-5.4%) on Sep 29, 2026
Alligator Bioscience announces final outcome in rights issue
Sep 22, 2026
Closed 0.02 (-4.7%) on Sep 23, 2026
Alligator Bioscience announces preliminary outcome in rights issue
Sep 21, 2026
Closed 0.021 (-8.7%) on Sep 21, 2026
Alligator Bioscience publishes prospectus in connection with rights issue
Aug 31, 2026
Closed 0.021 (+3.0%) on Aug 31, 2026
Bulletin from the Extraordinary General Meeting in Alligator Bioscience AB
Aug 26, 2026
Closed 0.024 (+22.3%) on Aug 26, 2026
Invitation to Alligator Bioscience's Earnings Call on 26 August 2026
Aug 20, 2026
Closed 0.021 (-4.4%) on Aug 20, 2026
Alligator discontinues independent development of mitazalimab for a strategic refocus on the HLX22 project, announces a rights issue of units of approximately SEK 125.6 million and raises bridge loans
Jul 23, 2026
Closed 0.034 (-74.0%) on Jul 23, 2026
Alligator announces first patient dosed in investigator-initiated study of intratumoral mitazalimab in early-stage breast cancer
Jul 2, 2026
Closed 0.118 (+1.9%) on Jul 2, 2026
Alligator Bioscience AB reports financial results for the period 1 January – 31 March 2026 and provides a business update
May 5, 2026
Closed 0.145 (+0.5%) on May 5, 2026
Financings
Rights offering of units of ordinary shares and warrants series TO 15 and TO 16
Sep 22, 2026 · US$5.97M
Closed: SEK 58.8M raised · SEK 0.04 a unit · each unit consists of two ordinary shares, one warrant series TO 15 and one warrant… · APREA Partners AB +1
Dealers: APREA Partners AB, Vator Securities AB
Buyers: Roxette Photo S.A. (part of subscription undertakings totaling SEK 2 million); Søren Bregenholt (part of subscription undertakings totaling SEK 2 million); Vator Securities AB (guarantee commitments totaling SEK 56.8 million together with Mangold); Mangold Fondkommission AB (guarantee commitments totaling SEK 56.8 million together with Vator Securities)
Insiders: Existing shareholders including CEO Søren Bregenholt have entered into subscription undertakings totaling SEK 2 million
Use of proceeds: Repayment of bridge loans of SEK 19 million
Announced Jul 23, 2026 · Update Aug 26, 2026 · Update Aug 31, 2026 · Closed Sep 22, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 15 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 28 slides · Aug 26, 2026
Q1 2026 Earnings Presentation
Earnings · 28 slides · May 5, 2026
Investor Presentation (September 2025)
Investor deck · 32 slides · September 2025
Alligator Bioscience AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 76 in all · newest Oct 4, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Aug 26, 2026
- Decks
- 17 decks · latest September 2026
Where Alligator Bioscience AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:ATORX · Home listing · This page | Stockholm | Sweden | SEK |
| LSE:0RK9 | LSE | United Kingdom | SEK |
| LS Exchange:A41BED | LS Exchange | Germany | EUR |
| Lang & Schwarz:A41BED | Lang & Schwarz | Germany | EUR |
| Aquis:ATORXS | Aquis | United Kingdom | SEK |
| Frankfurt:7AL0 | Frankfurt | Germany | EUR |
| Aquis:ATORXS | Aquis | United Kingdom | SEK |
| Stuttgart:7AL0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Alligator Bioscience AB.